Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma

Objectives: The prognosis of patients presenting with stage IVB uterine serous carcinoma (USC) remains extremely poor, with a reported 5-year survival of <20%. Here were evaluate the survival impact of cytoreductive surgery and identify other prognostic factors in stage IVB USC. Methods: A multic...

Full description

Bibliographic Details
Main Authors: Jennifer McEachron, Nancy Zhou, Victoria Hastings, Michelle Bennett, Constantine Gorelick, Margaux J. Kanis, Yi-Chun Lee
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001228